Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2007-8-16
pubmed:abstractText
Activation of the cAMP/PKA pathway in the dopaminoceptive neurons of the striatum has been proposed to mediate the actions of various classes of drugs of abuse. Here, we show that, in the mouse nucleus accumbens and dorsal striatum, acute administration of morphine resulted in an increase in the state of phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) at Thr34, without affecting phosphorylation at Thr75. The ability of morphine to stimulate Thr34 phosphorylation was prevented by blockade of dopamine D1 receptors. DARPP-32 knockout mice and T34A DARPP-32 mutant mice displayed a lower hyperlocomotor response to a single injection of morphine than wild-type controls. In contrast, in T75A DARPP-32 mutant mice, morphine-induced psychomotor activation was indistinguishable from that of wild-type littermates. In spite of their reduced response to the acute hyperlocomotor effect of morphine, DARPP-32 knockout mice and T34A DARPP-32 mutant mice were able to develop behavioral sensitization to morphine comparable to that of wild-type controls and to display morphine conditioned place preference. These results demonstrate that dopamine D1 receptor-mediated activation of the cAMP/DARPP-32 cascade in striatal medium spiny neurons is involved in the psychomotor action, but not in the rewarding properties, of morphine.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0893-133X
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1995-2003
pubmed:dateRevised
2011-5-18
pubmed:meshHeading
pubmed-meshheading:17251906-Animals, pubmed-meshheading:17251906-Behavior, Animal, pubmed-meshheading:17251906-Conditioning, Operant, pubmed-meshheading:17251906-Corpus Striatum, pubmed-meshheading:17251906-Cyclic AMP, pubmed-meshheading:17251906-Cyclic AMP-Dependent Protein Kinases, pubmed-meshheading:17251906-Dopamine and cAMP-Regulated Phosphoprotein 32, pubmed-meshheading:17251906-Dose-Response Relationship, Drug, pubmed-meshheading:17251906-Drug Interactions, pubmed-meshheading:17251906-Enzyme Activation, pubmed-meshheading:17251906-Enzyme Inhibitors, pubmed-meshheading:17251906-Male, pubmed-meshheading:17251906-Mice, pubmed-meshheading:17251906-Mice, Inbred C57BL, pubmed-meshheading:17251906-Mice, Knockout, pubmed-meshheading:17251906-Morphine, pubmed-meshheading:17251906-Motor Activity, pubmed-meshheading:17251906-Narcotics, pubmed-meshheading:17251906-Psychomotor Performance, pubmed-meshheading:17251906-Reward, pubmed-meshheading:17251906-Signal Transduction, pubmed-meshheading:17251906-Time Factors
pubmed:year
2007
pubmed:articleTitle
Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
pubmed:affiliation
Department of Neuroscience, Karolinska Institutet, Retzius väg 8, 17177 Stockholm, Sweden.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural